Bionano Genomics, Inc. (BNGO) vs Meihua International Medical Technologies Co., Ltd. (MHUAF)

Bionano Genomics, Inc. and Meihua International Medical Technologies Co., Ltd. are both Medical Instruments & Supplies companies. Bionano Genomics, Inc. is the larger, with a market value of $19.9M against $4.3M — 4.7× the size. Across the 11 metrics below, Meihua International Medical Technologies Co., Ltd. leads on 8 and Bionano Genomics, Inc. on 3.

Valuation

Metric BNGO MHUAF Medical Instruments & Supplies median
P/E n/m — 34.17
P/S 0.64 n/m 2.83
P/B 0.61 n/m 2.82
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales 0.49 n/m 3.06
Earnings yield (180.84%) — (1.84%)
Free cash flow yield (106.75%) 0.00% 0.17%

Profitability

Metric BNGO MHUAF Medical Instruments & Supplies median
Gross margin 47.51% — 54.62%
Operating margin (106.67%) — 1.64%
Net margin (106.58%) — 0.00%
Free cash flow margin (67.87%) 0.00% 1.61%
Return on equity (83.56%) 0.00% 0.00%
Return on assets (52.04%) 0.00% 0.00%
Return on invested capital (81.68%) 0.00% 0.00%

Growth

Metric BNGO MHUAF Medical Instruments & Supplies median
Revenue growth (TTM) 10.03% — 9.20%
EPS growth (last fiscal year) 94.50% (54.91%) —
Revenue growth, 5-year CAGR 27.37% (7.05%) 9.48%
Net income growth, 5-year CAGR 0.00% (18.66%) 0.00%

Health

Metric BNGO MHUAF Medical Instruments & Supplies median
Debt to equity 0.11 0.05 0.08
Current ratio 2.48 8.42 2.49
Net debt to EBITDA 1.06 (0.70) 0.83

Dividend

Metric BNGO MHUAF Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio 0.00 0.00 0.00

Size

Metric BNGO MHUAF Medical Instruments & Supplies median
Market cap 19.90m 4.25m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack